Psychedelic-assisted therapy has not only proven effective in alleviating terminally ill patients' anxiety, but has also yielded promising results in treating a variety of intractable psychological conditions over the years.
Fifty years after Tom Wolfe documented that epic LSD trip on a bus called "Further," a new breed of scientists is attempting once again to put Schedule I drugs into words (peer-reviewed ones, thankfully). The rigorous and careful exploration of these substances points to four key benefits.
The point of this post is not to promote the use of hallucinogens, but understanding the biological and psychological mechanisms by which psilocybin exerts its effects is important, as we may be able to simulate the effects using other methods.
I'm looking at you, Johns Hopkins University, for once again coming out with a timid little study reinforcing what everyone already knew. Once again, we find that magic mushrooms really are rather astonishing wonderfungi.
Kept on hold for close to half a century, especially in the U.S., psychedelic science is now coming back to life, in large part due to efforts by the Multidisciplinary Association for Psychedelic Studies.